Despite the multiplication of specialised centres and a fall in the birth rate, paediatric cardiac units have seen a steady increase in the number of infants with congenital heart defects operated on during the neonatal period. This changing pattem is the result of continuing advances in neonatology, early detection and better management of the neonate with a congenital heart defect, and the tendency, rightly or wrongly, to operate on more complex defects.
Advances in neonatology with improved infant care and ventilatory support for infants with respiratory distress syndrome have increased the neonatal survival rate. Hence the increase in the number of premature infants with a persistent ductus ateriosus who require surgical closure, often after a trial of treatment with indomethacin.
More specifically the preoperative status of neonates with congenital heart defects has been greatly improved by the introduction of prostaglandins and a trend to non-invasive diagnosis. Conventional clinical diagnosis of congenital heart defects by physical examination, chest de Leval New trends in the management of complete transposition of the great arteries illustrate the impact made by innovative surgery. Though intra-atrial repair oftransposition of the great arteries by either the Mustard or Senning techniques has been widely used for many years, there is concern about the very long term results of these interventions. Jatene and colleagues introduced the arterial switch or so called anatomical repair of transposition of the great arteries.' This was successfully applied to transposition with raised left ventricular pressure due to either a large left to right shunt or dynamic left ventricular outflow tract obstruction. The concept was more recently extended to the correction of simple transposition of the great arteries during the neonatal period at a time when the pulmonary vascular resistance is still so high that the left ventricle is capable of sustaining the systemic circulation after the switch procedure. The early results of this management have been very encouraging. The prospect of improved long term results would justify a wider use of this approach if late complications could be avoided. Because this remains a hypothetical prospect some units, such as ours, continue to be rather conservative about the management of simple transposition of the great arteries.
Progress in neonatology, the availability of reliable pharmacological and surgical means to regulate the pulmonary blood flow, and the fundamental demonstration that the pulmonary and the systemic circulations left in series could be successfully served by one ventricle (Fontan operation) have made the most complex cardiac malformations amenable to surgery. These developments account for changes in the management of hypoplastic right and left heart syndromes. The latter is the fourth most common congenital cardiac anomaly seen in infancy (after ventricular septal defect, tetralogy of Fallot, and transposition of the great arteries) and is responsible for nearly 25% of cardiac deaths during the first week of life. Closure of the arterial duct in the first few days of life explains the early death of so many neonates with hypoplastic left heart syndromes. On the assumption that hypoplastic left heart syndrome is very similar to extreme forms of right ventricular hypoplasia, tricuspid atresia, and other forms of univentricular hearts Norwood and his colleagues have developed palliative procedures for such patients.2
The purpose of these interventions is to establish a permanent communication between the right ventricle and the aorta, regulate the pulmonary blood flow (avoiding pulmonary vascular changes secondary to increased flow and pressure), and to assure a satisfactory interatrial communication. The definitive repair consists of separating the systemic and pulmonary circulations by performing a Fontan type Surgical management of the neonate with congenital heart disease 3 of procedure. We have followed with interest the evolution and the careful and systematic study of Norwood and his colleagues. 2 We believe that such a planned research programme should be supported but we think that it is premature for all surgical teams to embark on these often heroic surgical treatments without their knowing how many of the survivors of the first stage operation will eventually be suitable for a Fontan procedure. If their numbers are very small is it ethically justifiable to oblige patients who would otherwise have died as neonates to carry their handicap into childhood only to succumb because no further treatment is possible?
Neonatal cardiac transplantation with a homograft or even a xenograft heart is an altemative approach to treatment of patients with these complex malformations. Both procedures have already been performed. Are these pioneering endeavours going to open the doors to new hopes or create formidable problems?
One can predict that in the foreseeable future a number of researches that are currently underway will deeply influence the incidence and the management of neonates with congenital heart defects. Some workers are investigating the possibilities of operating on fetal hearts in utero because they consider that the womb is likely to be a better postoperative environment than the most advanced incubators. In several centres intrauterine echocardiographic diagnosis of complex cardiac malformations has led to the termination of pregnancy. In future the attitude towards the treatment of complex cardiac malformations in neonates will be based on the quality of adult life enjoyed by patients operated on today and on the outcomes of these two conflicting and radical tendencies, that is to replace the defective organ or to prevent the birth of the faulty embryo. Ethical, social, and economic considerations must also influence this subtle decision making.
